Simon F Lacey

10PUBLICATIONS
151CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyInnate immunityMolecular targetsMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 28, 2023
Phase I Trial of Autologous RNA-electroporated cMET-directed CAR T Cells Administered Intravenously in Patients with Melanoma and Breast Carcinoma.

Payal D Shah, Alexander C Huang, Xiaowei Xu

|Nov 22, 2022
Anti-BCMA/CD19 CAR T Cells with Early Immunomodulatory Maintenance for Multiple Myeloma Responding to Initial or Later-Line Therapy.

Alfred L Garfall, Adam D Cohen, Sandra P Susanibar-Adaniya

|Aug 26, 2022
Changes in Bone Marrow Tumor and Immune Cells Correlate with Durability of Remissions Following BCMA CAR T Therapy in Myeloma.

Kavita M Dhodapkar, Adam D Cohen, Akhilesh Kaushal

|Jul 29, 2022
Modulation of BCL-2 in Both T Cells and Tumor Cells to Enhance Chimeric Antigen Receptor T-cell Immunotherapy against Cancer.

Yong Gu Lee, Puneeth Guruprasad, Guido Ghilardi

|Sep 16, 2021
The Safety of Bridging Radiation with Anti-BCMA CAR T-Cell Therapy for Multiple Myeloma.

Shwetha H Manjunath, Adam D Cohen, Simon F Lacey

|Jul 17, 2020
Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications.

Divij Mathew, Josephine R Giles, Amy E Baxter

Pageof 2

Frequent Collaborators

7 joint publications

Carl H June

4 joint publications

Joseph A Fraietta

4 joint publications

Adam D Cohen

4 joint publications

Gabriela Plesa